Live feed
·
INSIDERFilingvia Quantisnow
Vyant Bio Inc. logo

Vyant Bio (VYNT) executive Yeh bought 1,000 shares for $2,640 at $2.64

ByQuantisnow·Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Insider transactions reported

Yung-Ping Yeh (executive at Vyant Bio Inc., VYNT) reported that they bought 1,000 shares for $2,640 at $2.64 on Aug 25, 2021. After these transactions the filing shows 12,262 shares held directly.

Reporting person
Yeh Yung-Ping
Common stock and other non-derivative transactions
DateTypeSecuritySharesPriceValueHeld after
Aug 25, 2021Open-market purchase (P)Common Stock, $0.0001 par value+1,000$2.64$2,64012,262 direct

Holdings before and after

  • Common Stock, $0.0001 par value: 11,262 to 12,262 direct

Other positions listed

  • Common Stock, $0.0001 par value: 1,315,363 indirect, By Trust

Transaction codes in this filing

Open-market purchase:
Code P marks a purchase in the open market or a private deal. The insider paid for these securities.

FAQ

What did Yeh report in this VYNT Form 4?

Yung-Ping Yeh (executive at Vyant Bio Inc., VYNT) reported that they bought 1,000 shares for $2,640 at $2.64 on Aug 25, 2021. After these transactions the filing shows 12,262 shares held directly.

How many VYNT shares does Yeh hold after this filing?

The filing shows 12,262 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.

What does transaction code P mean on an SEC Form 4?

Code P marks a purchase in the open market or a private deal. The insider paid for these securities.

Historical context for VYNT

Earlier insider filings at VYNT

Quantisnow market dataNASDAQ
Vyant Bio Inc. logo
VYNT
Vyant Bio Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Get push alerts for VYNT

Follow VYNT and get a push notification the moment its next story breaks.

Full VYNT profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VYNT (Vyant Bio Inc.) and more on Quantisnow.